Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;85(5):e22246.
doi: 10.1002/ddr.22246.

Therapeutic effects of tilorone on mammary carcinogenesis through downregulation of pro-inflammatory cytokines and oxidative stress

Abu Sufiyan Chhipa  1 , Ayush Sharma  1 , Srashti Verma  1 , Snehal S Patel  1
Affiliations

Therapeutic effects of tilorone on mammary carcinogenesis through downregulation of pro-inflammatory cytokines and oxidative stress

Abu Sufiyan Chhipa et al. Drug Dev Res. 2024 Aug.

Abstract

Tilorone dihydrochloride (tilorone) is an orally active interferon inducer with anticancer effects. The present study aimed to evaluate the anticancer effects of tilorone in breast cancer. MTT assay was done to measure the proliferation of MCF-7 and MDA-MB-231 breast cancer cells after treatment with tilorone. Mammary carcinogenesis was induced by subcutaneous injection (35 mg/kg, 0.5 mL) of dimethylbenz[a]anthracene (DMBA) in mammary pads of Sprague Dawley (SD) rats. Tumors were allowed to grow for 16 weeks till their sizes reached to 550-700 mm3, and then treated with 10 and 20 mg/kg of tilorone and standard drug doxorubicin (4 mg/kg) twice a week for 3 weeks. Normal and disease-control animals received normal saline. Tumor volumes and body weights were measured. Tumors were isolated to measure the levels of interferon-β (IFN-β), vascular endothelial growth factor-A (VEGF-A), P53 and inflammatory markers by enzyme-linked immunosorbent assay (ELISA). Serum biochemistry, lipid peroxidation (LPO) and antioxidant enzymes were measured by standard methods. Histopathology and immunohistochemistry (IHC) of P53 was done in tumor sections. Tilorone reduced the proliferation of MCF-7 and MDA-MB-231 cells with IC50 concentrations at 34.08 µM and 14.27 µM, respectively. Tilorone treatment showed reduced tumor volume, and increased survival with no significant changes in the body weights. Tilorone treatment also decreased levels of inflammatory markers and VEGF-A and increased IFN-β and P53 levels. Further, treatment with tilorone also decreased LPO and increased antioxidants levels. Histopathology of tumor sections showed normalizing morphology of treated animals. IHC of tumor sections showed increased levels of P53. In conclusion, tilorone has potential anticancer effects against breast cancer.

Keywords: anticancer; breast cancer; inflammation; interferon; oxidative stress; tilorone.

PubMed Disclaimer

References

REFERENCES

    1. Abd El‐Salam, M., El‐Tanbouly, G., Bastos, J., & Metwaly, H. (2023). Suppression of VEGF and inflammatory cytokines, modulation of annexin A1 and organ functions by galloylquinic acids in breast cancer model. Scientific Reports, 13(1), 12268. https://doi.org/10.1038/s41598-023-37654-4
    1. Akhouri, V., Kumari, M., & Kumar, A. (2020). Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats. Scientific Reports, 10(1), 18016. https://doi.org/10.1038/s41598-020-72935-2
    1. Alem, M., Shahbazfar, A., Zare, P., & Tayefi‐Nasrabadi, H. (2019). The effects of coadministration of tilorone dihydrochloride and culture supernatants from Lactobacillus reuteri on the mouse hepatoma cell line. Journal of cancer research and therapeutics, 15(1), 176.
    1. Alkabban, F. M., & Ferguson, T. (2023). Breast cancer. In StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Troy Ferguson declares no relevant financial relationships with ineligible companies. StatPearls Publishing LLC.
    1. Anderson, M. E. (1985). Determination of glutathione and glutathione disulfide in biological samples. Methods in Enzymology, 113, 548–555. https://doi.org/10.1016/s0076-6879(85)13073-9

MeSH terms

LinkOut - more resources